Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Gastrointest Endosc. 2012 Feb;75(2):294-301. doi: 10.1016/j.gie.2011.09.026. Epub 2011 Dec 9.
Although self-expandable metal stent (SEMS) insertion has been shown to be an effective therapy for palliation of obstruction from colorectal malignancy, the clinical efficacy of SEMS insertion in the palliation of colorectal obstruction from an extracolonic malignancy (ECM) has not been extensively evaluated.
The aim of this study was to evaluate the clinical outcomes and complications of SEMSs compared with those of emergency surgery for relief of colorectal obstruction in patients with advanced gastric cancer (AGC).
Retrospective study.
From January 2000 to December 2009, patients with AGC who were treated with SEMSs (N = 111) or emergency surgery (N = 69) for palliation of malignant colorectal obstruction were included.
SEMS insertion or surgery.
Although acute complications and stoma formations were lower in the SEMS group than in the surgery group, the clinical efficacy of SEMSs was inferior to emergency surgery (technical success, 73.9% vs 94.2%, P = .001; clinical success, 54.1% vs 75.4%, P = .005). SEMS-related complications occurred in 64.5%, including reobstruction (36.8%), stent migration (10.5%), perforation (13.2%), and bleeding (3.9%). The median duration of patency was not statistically different between the patients who underwent SEMS insertion and those who underwent emergency surgery (117 days vs 183 days, P = .105). Patients with fewer than 2 obstructive sites or less than 2 years to obstructive symptom onset after diagnosis of AGC showed better clinical outcomes after endoscopic stenting.
Retrospective and single-center study.
SEMS insertion seems to be less effective than emergency surgery for the palliation of colorectal obstruction in patients with AGC. Further study is necessary to define those patients with ECM who may benefit from SEMS insertion.
虽然自膨式金属支架(SEMS)置入术已被证明是缓解结直肠恶性肿瘤所致梗阻的有效治疗方法,但 SEMS 置入术在缓解结外恶性肿瘤(ECM)所致结直肠梗阻方面的临床疗效尚未得到广泛评估。
本研究旨在评估 SEMS 与急诊手术治疗晚期胃癌(AGC)患者结直肠梗阻的临床效果和并发症。
回顾性研究。
2000 年 1 月至 2009 年 12 月,111 例接受 SEMS 治疗(SEMS 组)和 69 例接受急诊手术治疗(手术组)姑息治疗恶性结直肠梗阻的 AGC 患者纳入研究。
SEMS 置入术或手术。
SEMS 组的急性并发症和造口形成率低于手术组,但 SEMS 的临床疗效劣于急诊手术(技术成功率为 73.9%比 94.2%,P=.001;临床成功率为 54.1%比 75.4%,P=.005)。SEMS 相关并发症发生率为 64.5%,包括再梗阻(36.8%)、支架移位(10.5%)、穿孔(13.2%)和出血(3.9%)。SEMS 组和手术组的支架通畅时间中位数无统计学差异(117 天比 183 天,P=.105)。接受内镜支架置入术的患者中,梗阻部位少于 2 个或诊断 AGC 后梗阻症状出现时间少于 2 年者,临床结局较好。
回顾性和单中心研究。
SEMS 置入术治疗 AGC 患者结直肠梗阻的效果劣于急诊手术。进一步研究有必要明确哪些 ECM 患者可能从 SEMS 置入术获益。